![Brett A. Erkman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brett A. Erkman
Private Equity Investor chez
Great Point Partners Private Equity
Profil
Mr. Brett A. Erkman is a Managing Director at Deep Track Capital LP and a Managing Director at Great Point Partners Private Equity.
He has over two decades of experience in healthcare finance.
Prior to joining Deep Track Capital, he was a Managing Director at Great Point Partners, where he began working with David Kroin in 2006 on the equity long/short biotechnology hedge fund.
Earlier in his career, Mr. Erkman was a sell-side research associate at ThinkEquity Partners in San Francisco and a senior financial analyst at Abbott Laboratories in the Global Pharmaceutical R&D division, now known as Abbvie.
Mr. Erkman earned a Bachelor of Science in Finance from DePaul University.
Postes actifs de Brett A. Erkman
| Sociétés | Poste | Début |
|---|---|---|
Great Point Partners Private Equity
 Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Private Equity Investor | 01/01/2006 |
Deep Track Capital LP
 Deep Track Capital LP Investment ManagersFinance Provides investment advice | Analyst-Equity | 01/10/2022 |
Anciens postes connus de Brett A. Erkman
| Sociétés | Poste | Fin |
|---|---|---|
Great Point Partners LLC
 Great Point Partners LLC Investment ManagersFinance Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies. | Analyst-Equity | 01/04/2022 |
ThinkEquity Partners
 ThinkEquity Partners Investment ManagersFinance Provides investment advice and security brokerage services | Analyst-Equity | - |
Formation de Brett A. Erkman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ThinkEquity Partners
ThinkEquity Partners Investment ManagersFinance Provides investment advice and security brokerage services | Finance |
Great Point Partners LLC
Great Point Partners LLC Investment ManagersFinance Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies. | Finance |
DePaul University
 DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Great Point Partners Private Equity
Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Finance |
Deep Track Capital LP
Deep Track Capital LP Investment ManagersFinance Provides investment advice | Finance |
